PARP1 and breast cancer: A genetic loss of PARP-1 has been shown to accelerate the induction of mammary tumours in mice.34 PARP-1 deletion is not equivalent to inhibition by niraparib, which efficiently traps the enzyme on DNA,10 but further experiments would be helpful to test whether long-term in vivo PARP inhibitor treatment has a detectable carcinogenic effect.